Inhibitory effect of threo-9,10-dichlorostearic acid on the mutagenic activity of MeIQx, 2-AF and B[a]P in the Ames/Salmonella test.
The mutagenic activity of threo-9,10-dichlorostearic acid, one of the chlorinated fatty acids identified in fish lipids, was examined in the Ames/Salmonella test. No mutagenic activity was found on any of the Salmonella typhimurium strains TA 98, TA 100 and TA 102, either with or without S9 activation. On the other hand, dichlorostearic acid showed an inhibitory effect on the mutagenic activity of the indirectly-acting mutagens 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-aminofluorene (2-AF) and benzo[a]pyrene (B[a]P) using strain TA 98 in the presence of S9. However, no inhibition was observed when mixing MeIQx and S9 before the addition of dichlorostearic acid. Furthermore, dichlorostearic acid did not show any inhibitory effect on the mutagenic activity of the directly-acting mutagen 4-nitroquinoline-N-oxide (4NQO) using the tester strains TA 98 and TA 100. We, therefore, suggest that dichlorostearic acid interacts with the enzymes of the S9 mix, thereby dose-dependently inhibiting the transformation of MeIQx, 2-AF and B[a]P into their active forms.
Vereskuns
G
G
Department of Applied Nutrition and Food Chemistry, Center for Chemistry and Chemical Engineering, Lund University, P.O. Box 124, SE-221 00, Lund, Sweden. gastons.vereskuns@teknlk.lth.se
Wesén
C
C
Skog
K
K
Jägerstad
M
M
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology; D016587:Antimutagenic Agents / Q000494:pharmacology*; D001564:Benzo(a)pyrene / Q000633:toxicity; D005449:Fluorenes / Q000633:toxicity; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D011810:Quinoxalines / Q000633:toxicity; D012486:Salmonella typhimurium; D013229:Stearic Acids / Q000494:pharmacology* / Q000633:toxicity
C114375:9,10-dichlorostearic acid; D016587:Antimutagenic Agents; D005449:Fluorenes; D009153:Mutagens; D011810:Quinoxalines; D013229:Stearic Acids; D001564:Benzo(a)pyrene; C012177:2-aminofluorene; D015112:4-Nitroquinoline-1-oxide; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline